Eduardo Salido

10.5k total citations
222 papers, 7.2k citations indexed

About

Eduardo Salido is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Eduardo Salido has authored 222 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Molecular Biology, 58 papers in Pulmonary and Respiratory Medicine and 46 papers in Genetics. Recurrent topics in Eduardo Salido's work include Kidney Stones and Urolithiasis Treatments (44 papers), Porphyrin Metabolism and Disorders (35 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Eduardo Salido is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (44 papers), Porphyrin Metabolism and Disorders (35 papers) and Renal Transplantation Outcomes and Treatments (20 papers). Eduardo Salido collaborates with scholars based in Spain, United States and United Kingdom. Eduardo Salido's co-authors include Larry J. Shapiro, Armando Torres, Pauline H. Yen, Vı́ctor de Lorenzo, Ángel L. Pey, L. Barajas, D A Fisher, P. H. Yen, T. Mohandas and Domingo Hernández and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eduardo Salido

216 papers receiving 7.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eduardo Salido Spain 48 3.8k 1.6k 1.4k 928 710 222 7.2k
Emile de Heer Netherlands 47 2.9k 0.7× 1.1k 0.7× 1.7k 1.2× 927 1.0× 1.1k 1.5× 204 8.5k
Äkïhïko Okuyama Japan 50 3.3k 0.9× 1.7k 1.1× 1.4k 1.0× 379 0.4× 1.9k 2.7× 479 9.4k
Patricia D. Wilson United States 55 5.0k 1.3× 1.0k 0.6× 3.5k 2.6× 1.4k 1.5× 939 1.3× 179 8.3k
Masafumi Matsuo Japan 46 5.2k 1.3× 827 0.5× 1.3k 1.0× 272 0.3× 739 1.0× 395 8.3k
Takehiko Koji Japan 45 3.2k 0.8× 711 0.4× 893 0.7× 441 0.5× 1.0k 1.4× 231 7.2k
Bernard Grandchamp France 58 5.8k 1.5× 1.2k 0.7× 833 0.6× 433 0.5× 524 0.7× 228 11.5k
Hugh R. Brady Ireland 50 3.0k 0.8× 885 0.5× 565 0.4× 558 0.6× 922 1.3× 125 7.9k
Hermann-Josef Gröne Germany 62 5.0k 1.3× 997 0.6× 878 0.6× 512 0.6× 1.2k 1.7× 170 11.9k
Jan‐Gowth Chang Taiwan 43 4.4k 1.1× 605 0.4× 742 0.5× 478 0.5× 809 1.1× 329 8.2k
P Verroust France 55 3.5k 0.9× 738 0.4× 620 0.5× 1.1k 1.1× 980 1.4× 163 8.5k

Countries citing papers authored by Eduardo Salido

Since Specialization
Citations

This map shows the geographic impact of Eduardo Salido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eduardo Salido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eduardo Salido more than expected).

Fields of papers citing papers by Eduardo Salido

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eduardo Salido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eduardo Salido. The network helps show where Eduardo Salido may publish in the future.

Co-authorship network of co-authors of Eduardo Salido

This figure shows the co-authorship network connecting the top 25 collaborators of Eduardo Salido. A scholar is included among the top collaborators of Eduardo Salido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eduardo Salido. Eduardo Salido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chenchu, Yan Shi, Manoj Kushwaha, et al.. (2025). Cholesterol metabolism regulated by CAMKK2-CREB signaling promotes castration-resistant prostate cancer. Cell Reports. 44(6). 115792–115792.
2.
Loginov, Dmitry S., Daniel Kavan, Eduardo Salido, et al.. (2022). Counterintuitive structural and functional effects due to naturally occurring mutations targeting the active site of the disease‐associated NQO1 enzyme*. FEBS Journal. 290(7). 1855–1873. 2 indexed citations
3.
Salido, Eduardo, et al.. (2022). Targeting HIF-1α Function in Cancer through the Chaperone Action of NQO1: Implications of Genetic Diversity of NQO1. Journal of Personalized Medicine. 12(5). 747–747. 12 indexed citations
4.
Loginov, Dmitry S., Rogelio Palomino‐Morales, Eduardo Salido, et al.. (2022). Allosteric Communication in the Multifunctional and Redox NQO1 Protein Studied by Cavity-Making Mutations. Antioxidants. 11(6). 1110–1110. 9 indexed citations
5.
Moya-Garzón, María Dolores, Cristina Martín-Higueras, Miguel X. Fernandes, et al.. (2022). New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production. European Journal of Medicinal Chemistry. 237. 114396–114396. 13 indexed citations
6.
Moreno-Rodriguez, Thaidy, Laura González-Silva, Carlos Revilla, et al.. (2021). ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer. Oncogene. 40(16). 2923–2935. 24 indexed citations
7.
Moya-Garzón, María Dolores, José A. Gómez-Vidal, Alfonso Alejo‐Armijo, et al.. (2021). Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of Personalized Medicine. 11(2). 74–74. 1 indexed citations
8.
Palomino‐Morales, Rogelio, Noel Mesa‐Torres, Eduardo Salido, et al.. (2021). Structural basis of the pleiotropic and specific phenotypic consequences of missense mutations in the multifunctional NAD(P)H:quinone oxidoreductase 1 and their pharmacological rescue. Redox Biology. 46. 102112–102112. 18 indexed citations
9.
González-Sánchez, Laura, Pilar López‐Nieva, María Villa‐Morales, et al.. (2019). Exploiting the passenger ACO1-deficiency arising from 9p21 deletions to kill T-cell lymphoblastic neoplasia cells. Carcinogenesis. 41(8). 1113–1122. 8 indexed citations
10.
Kukreja, Anjli, Melissa A. Lasaro, Jianping Tang, et al.. (2019). Systemic Alanine Glyoxylate Aminotransferase mRNA Improves Glyoxylate Metabolism in a Mouse Model of Primary Hyperoxaluria Type 1. Nucleic Acid Therapeutics. 29(2). 104–113. 15 indexed citations
11.
Moya-Garzón, María Dolores, Cristina Martín-Higueras, Pablo Peñalver, et al.. (2018). Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1. Journal of Medicinal Chemistry. 61(16). 7144–7167. 20 indexed citations
12.
Tamajón, Lourdes Pérez, et al.. (2017). Influence of genetic polymorphisms of CYP3A5 and ABCB1 on sirolimus pharmacokinetics, patient and graft survival and other clinical outcomes in renal transplant. Drug Metabolism and Personalized Therapy. 32(1). 49–58. 9 indexed citations
13.
Scala, Marianna Di, Eduardo Salido, Esperanza López‐Franco, et al.. (2016). Transient Expression of Transgenic IL-12 in Mouse Liver Triggers Unremitting Inflammation Mimicking Human Autoimmune Hepatitis. The Journal of Immunology. 197(6). 2145–2156. 24 indexed citations
14.
Medina‐Carmona, Encarnación, Rogelio Palomino‐Morales, Julian E. Fuchs, et al.. (2016). Conformational dynamics is key to understanding loss-of-function of NQO1 cancer-associated polymorphisms and its correction by pharmacological ligands. Scientific Reports. 6(1). 20331–20331. 38 indexed citations
15.
Barrios, Ysamar, Miguel Andújar, Liya Gu, et al.. (2012). The hMSH2(M688R) Lynch syndrome mutation may function as a dominant negative. Carcinogenesis. 33(9). 1647–1654. 7 indexed citations
16.
Kanaoka, Yoshihide, Naomi Eguchi, Kosuke Aritake, et al.. (2007). Hematopoietic Prostaglandin D Synthase Suppresses Intestinal Adenomas in Apc Min/+ Mice. Cancer Research. 67(3). 881–889. 48 indexed citations
17.
Porrini, Esteban, Patricia Delgado, Alejandra Alvarez, et al.. (2006). Impact of Metabolic Syndrome on Graft Function and Survival After Cadaveric Renal Transplantation. American Journal of Kidney Diseases. 48(1). 134–142. 119 indexed citations
18.
Torres, Armando, et al.. (2003). Patología molecular de la hiperoxaluria: Primaria. Nefrología. 23(1). 90–97. 2 indexed citations
19.
Compagnone, Nathalie A., Eduardo Salido, Larry J. Shapiro, & Synthia H. Mellon. (1997). Expression of Steroid Sulfatase during Embryogenesis*. Endocrinology. 138(11). 4768–4773. 45 indexed citations
20.
Salido, Eduardo, et al.. (1994). Cloning of the mouse steroid sulfatase (Sts) gene. The American Journal of Human Genetics. 55. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026